Generated by DeepSeek V3.2| ascites | |
|---|---|
| Name | Ascites |
| Caption | Computed tomography scan showing ascites (dark areas) in the abdominal cavity. |
| Field | Gastroenterology, Hepatology |
| Symptoms | Abdominal swelling, discomfort, shortness of breath |
| Complications | Spontaneous bacterial peritonitis, hepatorenal syndrome, umbilical hernia |
| Causes | Cirrhosis, malignancy, heart failure, tuberculosis |
| Diagnosis | Physical examination, ultrasound, paracentesis |
| Treatment | Sodium restriction, diuretics, therapeutic paracentesis, transjugular intrahepatic portosystemic shunt |
| Medication | Spironolactone, furosemide |
| Prognosis | Depends on underlying cause; poor in cirrhosis with complications |
ascites. It is the pathological accumulation of fluid within the peritoneal cavity, most commonly arising as a complication of advanced liver disease. This condition leads to increased abdominal pressure and can cause significant discomfort and respiratory compromise. Diagnosis typically involves physical examination and imaging, while management focuses on treating the underlying cause and removing excess fluid.
Ascites is defined as the abnormal buildup of protein-containing fluid in the abdominal cavity. It is a common clinical finding in patients with portal hypertension, often due to cirrhosis from causes like alcoholism or chronic hepatitis B. The condition has been documented throughout medical history, with descriptions found in the texts of ancient physicians like Hippocrates. The development of therapeutic paracentesis and the understanding of its pathophysiology marked significant advances in the field of hepatology.
The most frequent cause is cirrhosis, accounting for approximately 85% of cases, often linked to alcoholic liver disease or hepatitis C. Other causes include malignancies such as ovarian cancer or pancreatic cancer, congestive heart failure, and infectious processes like tuberculous peritonitis. The primary mechanism in liver disease involves portal hypertension and splanchnic vasodilation, triggering the activation of the renin-angiotensin-aldosterone system and sodium retention by the kidneys. In malignant ascites, fluid accumulation results from peritoneal carcinomatosis and lymphatic obstruction.
Patients typically present with increasing abdominal girth, early satiety, and abdominal discomfort. Severe cases may lead to umbilical hernia or respiratory distress due to elevated diaphragm pressure. On examination, findings may include shifting dullness or a positive fluid wave test. Diagnostic evaluation begins with abdominal ultrasound to confirm the presence of fluid. A diagnostic paracentesis is then performed to analyze the ascitic fluid, measuring the serum-ascites albumin gradient to differentiate between portal hypertensive and other causes. Analysis also checks for signs of spontaneous bacterial peritonitis and cytology for malignant cells.
First-line management for ascites due to cirrhosis involves sodium restriction and oral diuretics, typically a combination of spironolactone and furosemide. For large-volume or refractory ascites, therapeutic paracentesis is performed to drain several liters of fluid, often with concurrent intravenous albumin administration to prevent post-paracentesis circulatory dysfunction. Refractory cases may require intervention with a transjugular intrahepatic portosystemic shunt to reduce portal pressure. For malignant ascites, treatment options include repeated paracentesis, indwelling peritoneal catheter placement, or systemic chemotherapy targeting the primary tumor.
The prognosis is closely tied to the underlying etiology. In patients with cirrhosis, the development of ascites signifies a poor prognosis, with a high risk of progressing to complications like spontaneous bacterial peritonitis, hepatorenal syndrome, and hepatic encephalopathy. The presence of refractory ascites is associated with a one-year survival rate of less than 50%. Other potential complications include pleural effusion (hepatic hydrothorax), abdominal wall hernia rupture, and protein-calorie malnutrition. Management of these complications often requires coordinated care by specialists in hepatology and transplant surgery, with liver transplantation being the definitive treatment for eligible patients with advanced liver disease.
Category:Digestive system